seed
Stage
2
Investors
About
Aperiam Bio uses computational algorithms to design hyperfolding protein variants that improve expression, solubility, and activity, enabling stable enzyme and therapeutic production for applications in cosmetics and pulmonary biologics.
Explore Aperiam Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.